Bain Capital Life Sciences Investors, Llc - Net Worth and Insider Trading

Over the past 18 months, Bain Capital Life Sciences Investors, Llc made no insider transaction in Annexon Inc (ANNX). Other recent insider transactions involving Annexon Inc (ANNX) include a net sale of 74,985 shares made by Ted Yednock , a net purchase of 22,400 shares made by William H. Carson , and a net sale of 6,563 shares made by Jennifer Lew .

In summary, during the past 3 months, insiders sold 20,908 shares of Annexon Inc (ANNX) in total and bought 6,400 shares, with a net sale of 14,508 shares. During the past 18 months, 92,392 shares of Annexon Inc (ANNX) were sold and 372,400 shares were bought by its insiders, resulting in a net purchase of 280,008 shares.

Annexon Inc (ANNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Bain Capital Life Sciences Investors, Llc made no insider transaction in Arcutis Biotherapeutics Inc (ARQT). Other recent insider transactions involving Arcutis Biotherapeutics Inc (ARQT) include a net sale of 204,518 shares made by Patrick Burnett , a net sale of 26,241 shares made by Masaru Matsuda , and a net sale of 60,000 shares made by Howard G. Welgus .

In summary, during the past 3 months, insiders sold 175,389 shares of Arcutis Biotherapeutics Inc (ARQT) in total and bought 0 shares, with a net sale of 175,389 shares. During the past 18 months, 390,095 shares of Arcutis Biotherapeutics Inc (ARQT) were sold and 102,515 shares were bought by its insiders, resulting in a net sale of 287,580 shares.

Arcutis Biotherapeutics Inc (ARQT)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Aptinyx Inc (APTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aptinyx Inc (APTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aptinyx Inc (APTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Dicerna Pharmaceuticals Inc (DRNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dicerna Pharmaceuticals Inc (DRNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Dicerna Pharmaceuticals Inc (DRNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Bain Capital Life Sciences Investors, Llc made no insider transaction in SpringWorks Therapeutics Inc (SWTX). Other recent insider transactions involving SpringWorks Therapeutics Inc (SWTX) include a net sale of 9,466 shares made by Julie Hambleton , a net sale of 98,000 shares made by Saqib Islam , and a net sale of 41,181 shares made by Daniel Pichl .

In summary, during the past 3 months, insiders sold 69,000 shares of SpringWorks Therapeutics Inc (SWTX) in total and bought 0 shares, with a net sale of 69,000 shares. During the past 18 months, 196,703 shares of SpringWorks Therapeutics Inc (SWTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 196,703 shares.

SpringWorks Therapeutics Inc (SWTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Bain Capital Life Sciences Investors, Llc made no insider transaction in Replimune Group Inc (REPL). Other recent insider transactions involving Replimune Group Inc (REPL) include a net sale of 45,658 shares made by Pamela Esposito , a net sale of 36,807 shares made by Konstantinos Xynos , and a net sale of 12,680 shares made by Christopher Sarchi .

In summary, during the past 3 months, insiders sold 12,453 shares of Replimune Group Inc (REPL) in total and bought 0 shares, with a net sale of 12,453 shares. During the past 18 months, 212,140 shares of Replimune Group Inc (REPL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 212,140 shares.

Replimune Group Inc (REPL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Bain Capital Life Sciences Investors, Llc made no insider transaction in Marinus Pharmaceuticals Inc (MRNS). Other recent insider transactions involving Marinus Pharmaceuticals Inc (MRNS) include a net sale of 18,588 shares made by Scott Braunstein , a net sale of 7,730 shares made by Joseph Hulihan , and a net sale of 7,461 shares made by Steven Pfanstiel .

In summary, during the past 3 months, insiders sold 0 shares of Marinus Pharmaceuticals Inc (MRNS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 45,796 shares of Marinus Pharmaceuticals Inc (MRNS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 45,796 shares.

Marinus Pharmaceuticals Inc (MRNS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Bain Capital Life Sciences Investors, Llc made no insider transaction in Rapid Micro Biosystems Inc (RPID). Other recent insider transactions involving Rapid Micro Biosystems Inc (RPID) include a net purchase of 104,000 shares made by Spignesi Robert G. Jr. , a net purchase of 20,000 shares made by Sean M Wirtjes , and a net purchase of 65,000 shares made by Richard S Kollender .

In summary, during the past 3 months, insiders sold 0 shares of Rapid Micro Biosystems Inc (RPID) in total and bought 20,000 shares, with a net purchase of 20,000 shares. During the past 18 months, 0 shares of Rapid Micro Biosystems Inc (RPID) were sold and 259,000 shares were bought by its insiders, resulting in a net purchase of 259,000 shares.

Rapid Micro Biosystems Inc (RPID)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Bain Capital Life Sciences Investors, Llc made no insider transaction in Xilio Therapeutics Inc (XLO). Other recent insider transactions involving Xilio Therapeutics Inc (XLO) include a net sale of 5,235 shares made by Atlas Venture Fund Xi, L.p. , and a net purchase of 485,250 shares made by Gilead Sciences Inc .

In summary, during the past 3 months, insiders sold 0 shares of Xilio Therapeutics Inc (XLO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 5,235 shares of Xilio Therapeutics Inc (XLO) were sold and 485,250 shares were bought by its insiders, resulting in a net purchase of 480,015 shares.

Xilio Therapeutics Inc (XLO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Bain Capital Life Sciences Investors, Llc made no insider transaction in Solid Biosciences Inc (SLDB). Other recent insider transactions involving Solid Biosciences Inc (SLDB) include a net sale of 1,743 shares made by Ilan Ganot , a net purchase of 3,410,713 shares made by Perceptive Life Sciences Master Fund Ltd , and a net purchase of 904,160 shares made by Ra Capital Healthcare Fund Lp .

In summary, during the past 3 months, insiders sold 2,923 shares of Solid Biosciences Inc (SLDB) in total and bought 0 shares, with a net sale of 2,923 shares. During the past 18 months, 26,705 shares of Solid Biosciences Inc (SLDB) were sold and 4,315,973 shares were bought by its insiders, resulting in a net purchase of 4,289,268 shares.

Solid Biosciences Inc (SLDB)'s detailed insider trading history can be found in Insider Trading Tracker table.